US probes target health care startup Theranos


Theranos Chief Executive Officer Elizabeth Holmes speaks on stage at the Glamour Women of the Year Awards where she receives an award, in the Manhattan borough of New York November 9, 2015. REUTERS/Carlo Allegri

SAN FRANCISCO: Theranos, a startup that touted a revolutionary new way to test blood, has revealed it is under scrutiny by US civil and criminal authorities. 

Investigations by the US Attorney’s Office and the Securities and Exchange Commission are ongoing, with documents being requested from the California-based company, Theranos told partners in a memo, a copy of which was obtained by AFP on April 18. 

Play, subscribe and stand a chance to win prizes worth over RM39,000! T&C applies.

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Tech News

Japan approves additional $4 billion for chipmaker Rapidus
Online, motherhood Is a test no one can pass
AI chatbots offer children harm as if it were help, says activist
OpenAI identifies security issue involving third-party tool, says user data was not accessed
Losing jobs and minds? AI effects will be far-reaching, analysts warn
US judge blocks Arizona criminal case against Kalshi at CFTC's request
How AI helped 1 man (and his brother) build a US$1.8 billion company
Proxy adviser Glass Lewis recommends Warner Bros shareholders vote for Paramount deal
Tesla's supervised self-driving software gets Dutch okay, first in Europe
IBM to pay $17 million to settle US government probe over DEI

Others Also Read